Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126702511 | 12670251 | 1 | I | 201507 | 20150728 | 20160821 | 20160821 | EXP | DK-DKMA-WBS-0000519 | DK-MYLANLABS-2016M1034541 | MYLAN | 0.00 | Y | 0.00000 | 20160818 | MD | DK | DK |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126702511 | 12670251 | 1 | PS | CLOZAPINE. | CLOZAPINE | 1 | Oral | 12.5 MG, QD | Y | U | 75417 | 12.5 | MG | QD | |||||
| 126702511 | 12670251 | 2 | SS | CLOZAPINE. | CLOZAPINE | 1 | Oral | 25 MG, QD | Y | U | 75417 | 25 | MG | QD | |||||
| 126702511 | 12670251 | 3 | SS | CLOZAPINE. | CLOZAPINE | 1 | Oral | 100 MG, QD | Y | U | 75417 | 100 | MG | QD | |||||
| 126702511 | 12670251 | 4 | C | ALFACALCIDOL ALTERNOVA | 2 | 0 | |||||||||||||
| 126702511 | 12670251 | 5 | C | ELTROXIN | LEVOTHYROXINE | 1 | 0 | ||||||||||||
| 126702511 | 12670251 | 6 | C | FEMSEPTCOMBI | 2 | 0 | |||||||||||||
| 126702511 | 12670251 | 7 | C | SEROQUEL | QUETIAPINE FUMARATE | 1 | 0 | ||||||||||||
| 126702511 | 12670251 | 8 | C | UNIKALK PLUS | 2 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126702511 | 12670251 | 1 | Schizophrenia |
| 126702511 | 12670251 | 4 | Calcium metabolism disorder |
| 126702511 | 12670251 | 5 | Myxoedema |
| 126702511 | 12670251 | 6 | Product used for unknown indication |
| 126702511 | 12670251 | 7 | Schizophrenia |
| 126702511 | 12670251 | 8 | Mineral supplementation |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126702511 | 12670251 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126702511 | 12670251 | Arthropod bite | |
| 126702511 | 12670251 | Cardiomyopathy | |
| 126702511 | 12670251 | Ejection fraction decreased | |
| 126702511 | 12670251 | Electrocardiogram QT prolonged | |
| 126702511 | 12670251 | Electrocardiogram T wave inversion | |
| 126702511 | 12670251 | Eosinopenia | |
| 126702511 | 12670251 | Fatigue | |
| 126702511 | 12670251 | Influenza like illness | |
| 126702511 | 12670251 | Malaise | |
| 126702511 | 12670251 | Myocardial necrosis marker increased | |
| 126702511 | 12670251 | Myocarditis | |
| 126702511 | 12670251 | Pyrexia | |
| 126702511 | 12670251 | Tachycardia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126702511 | 12670251 | 1 | 20150701 | 0 | ||
| 126702511 | 12670251 | 2 | 20150715 | 0 | ||
| 126702511 | 12670251 | 3 | 20150715 | 0 | ||
| 126702511 | 12670251 | 4 | 20150401 | 0 | ||
| 126702511 | 12670251 | 5 | 201008 | 0 | ||
| 126702511 | 12670251 | 6 | 20150413 | 0 | ||
| 126702511 | 12670251 | 7 | 20150429 | 0 |